EMEA-000826-PIP01-09

Key facts

Active substance
  • phentermine
  • topiramate
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/223/2010
PIP number
EMEA-000826-PIP01-09
Pharmaceutical form(s)
  • Capsule
  • hard
Condition(s) / indication(s)
Treatment of obesity
Route(s) of administration
Oral use
Contact for public enquiries
Vivus BV
Tam@vivus.com
United States
Phone: + 1 6509345200
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating